FP13.04 KEYNOTE-042 3-Year Survival Update: 1L Pembrolizumab vs Platinum-Based Chemotherapy for PD-L1+ Locally Advanced/Metastatic NSCLCByoung Chul Cho, Tony Mok, G. Lopes et al.|Journal of Thoracic Oncology|2021Cited by 28